[1]施斌斌 促红细胞生成素与慢性肝病的关系 [J] 医学综述 1998, 4 (11) ∶6 15
|
[][2 ]江中林 , 史康宁 , 张吉敏 , 等 肝病患者促红细胞生成素水平分析[J] 放射免疫学杂志 , 1999, 12 (2 ) ∶83
|
[3]周少雄 , 肖桂元 , 戴盛明等 病毒性肝炎患者的促红细胞生成素水平 [J] 中华肝脏病杂志 , 1997, 5 (4) ∶2 41
|
[4]郝秀华 , 颜光涛 , 奚永志等 红细胞生成素放射免疫分析方法的建立及初步临床应用 [J] 中华血液血学杂志 , 1998, 19 (6 ) ∶32 6
|
[][5 ]尹伯元 放射免疫分析在医学中的应用 [M] 北京 :原子能出版社 1991;95
|
[][6 ]谢天培 伴有红细胞增生患者的肝癌细胞可产生促红细胞生成素的免疫组化证据 [J] 《国外医学》消化系统疾病分册 , 1994, 14 (2 ) ∶12 3
|
[1] | Ziyi LI, Wanjie ZHANG, Fuchun WANG, Xiaorong MAO, Junfeng LI. Role of T lymphocytes in primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2926-2931. doi: 10.3969/j.issn.1001-5256.2023.12.026 |
[2] | Long LIU, Ke SHI, Qun ZHANG, Chongping RAN, Jie HOU, Yi ZHANG, Xianbo WANG. Risk factors for hepatocellular carcinoma in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2021, 37(7): 1589-1593. doi: 10.3969/j.issn.1001-5256.2021.07.022 |
[3] | Yuecheng YU, Chengwei CHEN. Pathogenesis of drug-induced liver injury: Current understanding and future needs[J]. Journal of Clinical Hepatology, 2021, 37(11): 2515-2524. doi: 10.3969/j.issn.1001-5256.2021.11.003 |
[4] | Qu Yao, Zhang Wei. Role of cell apoptosis in the pathogenesis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1397-1400. doi: 10.3969/j.issn.1001-5256.2019.06.049 |
[5] | Chang BinXia, Wang Hua, Zou ZhengSheng, Li BaoSen, Gao Bin. Pathogenesis and novel therapeutic targets of alcoholic liver disease[J]. Journal of Clinical Hepatology, 2014, 30(2): 113-117. doi: 10.3969/j.issn.1001-5256.2014.02.004 |
[6] | Liu HongHong, Fu JunLiang, Fu BaoYun, Zhang Zheng, Xu RuoNan, Luo ShengQiang, Shi Ming, Li YongGang, Wang FuSheng. The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 153-155. |
[7] | Luo FangQiong, Pan Yu, Liu JingJing, Zhang Peng, Niu JunQi, Jiang YanFang. The Impact of Adefovior dipivoxil on Th1/Th2 cytokines in chronic hepatitis B Patients[J]. Journal of Clinical Hepatology, 2010, 26(1): 19-21. |
[8] | Huang ZhongFa, Zhu Qing, Fu QiMei, Bu QuanHui, Shi BinBin. The effect of Interferon treatment on cellular immuneresponses in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(5): 326-328. |
[9] | Zhao Shuang, Yan XueBing, Wang JinZhang, Hao JunGui, Wang MingShan, Feng Xia, Wan MeiRong. The study on imblance of cytotoxic T cells subtype (Tc1/Tc2) in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(6): 417-419. |
[17] | Yin HongZhu, Liu JinXing, Cao ZhiChen, Li BingShun, Tang HuiHua, Feng ZhongJun. The Study of the role of Soluble Intercellular Adhesion Molecule-1 in Patients with Chronic hepatitis B[J]. Journal of Clinical Hepatology, 2000, 16(4): 230-231. |